Hemoptysis in CKD Patients on Hemodialysis

Common Causes of Hemoptysis

Respiratory tract infections, including bacterial pneumonia and tuberculosis, are common causes of hemoptysis in CKD patients, particularly in immunocompromised individuals 1, 2
Bronchiectasis is a leading cause of hemoptysis in tertiary referral centers and is more common in patients with chronic inflammatory conditions, including CKD patients on hemodialysis 1, 2
Pulmonary arteriovenous malformations, pulmonary pseudoaneurysms, and pulmonary artery aneurysms are potential vascular causes of hemoptysis in CKD patients on hemodialysis 1, 2
Malignancy, including primary lung cancer or metastatic disease, can cause hemoptysis in CKD patients on hemodialysis 1, 2
Immune-complex mediated diseases like HCV-associated glomerulonephritis can cause pulmonary-renal syndromes with hemoptysis in CKD patients on hemodialysis 3, 4

Quantify severity of hemoptysis, with massive hemoptysis (>100 mL in 24 hours) being life-threatening and requiring immediate intervention 1, 2
Assess for hypotension, tachycardia, and respiratory distress, which indicate severe hemoptysis requiring urgent management 5
Evaluate oxygen saturation and respiratory status to determine the impact on gas exchange 6
Chest radiography is the initial imaging modality, though limited in identifying the source of bleeding 1, 5
CT angiography is the preferred imaging modality for hemoptysis evaluation, providing detailed assessment of bronchial and non-bronchial systemic arteries 1, 2
High-resolution CT can evaluate for bronchiectasis, masses, and parenchymal disease 1

Secure the airway in cases of massive hemoptysis and consider selective intubation of the non-bleeding lung if necessary 1, 2
Provide supplemental oxygen and monitor oxygen saturation closely 6
Correct hypertension to target <140/90 mmHg pre-dialysis and <130/80 mmHg post-dialysis 6
Target hemoglobin of 11-12 g/dL as anemia correction can improve bleeding time in ESRD patients 6
Bronchial artery embolization is the preferred definitive treatment for severe or recurrent hemoptysis 1
Identify and embolize non-bronchial systemic arteries that may contribute to hemoptysis 1
Antimicrobial therapy for infectious causes based on culture results 1
For HCV-associated glomerulonephritis with pulmonary involvement, direct-acting antiviral therapy is recommended 3, 4

Regular screening and early treatment of respiratory infections can help prevent hemoptysis in CKD patients on hemodialysis 1
Vaccination against respiratory pathogens, including influenza and pneumococcus, is recommended for CKD patients on hemodialysis 4
Smoking cessation counseling can help reduce the risk of hemoptysis in CKD patients on hemodialysis 1